Author(s): Anil Kumar Kota, Mukthinuthalapati Mathrusri Annapurna

Email(s): mmukthin@gitam.edu

DOI: 10.52711/0974-360X.2022.00641   

Address: Anil Kumar Kota, Mukthinuthalapati Mathrusri Annapurna*
Department of Pharmaceutical Analysis, GITAM School of Pharmacy, Gandhi Institute of Technology and Management (Deemed to be University), Visakhapatnam, India.
*Corresponding Author

Published In:   Volume - 15,      Issue - 9,     Year - 2022


ABSTRACT:
Dolutegravir sodium, Lamivudine and Tenofovir disoproxil fumarate are anti-viral drugs. A new stability indicating UHPLC method has been proposed for the simultaneous determination of Dolutegravir sodium, Lamivudine and Tenofovir disoproxil fumarate tablets on gradient mode with 1.0mL/min flow rate and a diluent consisting of a mixture of phosphate buffer (pH 3.0) and acetonitrile (62: 38) was used for the study. Shimadzu NexeraX2 Model UPLC system with (PDA detector) Zorbax SB-C18 column (100mm × 4.60mm, 3.5µ) was employed for the present study. Beer-Lambert’s law was obeyed over the concentration range 5-900, 2-700 and 2-150µg/mL with linear regression equationsy = 1724.x-11307 (R² = 0.999), y = 1737.x-1009 (R² = 0.999) and y = 3538.x+587.5 (R² = 0.999) for Lamivudine, Tenofovir disoproxil fumarate and Dolutegravir sodium and the method was validated as per ICH guidelines. The LOQ values were found to be 4.4926, 1.8342 and 1.7963 µg/mL and that of LOD values as 1.4811. 0.6024 and 0.5903µg/mL forD Lamivudine, Tenofovir disoproxil fumarate and Dolutegravir sodium respectively. The combination of Dolutegravir sodium, Lamivudine and Tenofovir disoproxil fumarate was exposed to various stress conditions and the stability of the proposed method was carried out at UV detection 260nm. The proposed UHPLC method is simple, precise, accurate, robust and used for the routine analysis of tablet dosage forms.


Cite this article:
Anil Kumar Kota, Mukthinuthalapati Mathrusri Annapurna. A new Stability-indicating UHPLC for the simultaneous determination of a combination of Anti-viral drugs: Dolutegravir sodium, Lamivudine and Tenofovir disoproxil fumarate. Research Journal of Pharmacy and Technology. 2022; 15(9):3823-0. doi: 10.52711/0974-360X.2022.00641

Cite(Electronic):
Anil Kumar Kota, Mukthinuthalapati Mathrusri Annapurna. A new Stability-indicating UHPLC for the simultaneous determination of a combination of Anti-viral drugs: Dolutegravir sodium, Lamivudine and Tenofovir disoproxil fumarate. Research Journal of Pharmacy and Technology. 2022; 15(9):3823-0. doi: 10.52711/0974-360X.2022.00641   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-9-1


REFERENCES:
1.    Katlama C and Murphy R. Dolutegravir for the treatment of HIV. Expert OpinInvestig Drugs. 2012; 21(4): 523-530.
2.    Budavari S (Ed.). The Merck Index, 13th ed., Merck and Co., Inc, Whitehouse Station. NJ, USA. 2001, 1573.
3.    Mueller BU, Lewis LL, Yuen GJ, Farley M, Keller A, Church JA, Goldsmith JC, Venzon DJ, Rubin M, Pizzo PA and Balis FM. Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral Lamivudine in human immunodeficiency virus-infected children. Antimicrob Agents Chemother. 1998 42(12): 3187- 3192.
4.    Miller MD, Margot NA, Hertogs K, Larder B and Miller V. Antiviral activity of Tenofovir against nucleoside-resistant clinical HIV samples. Nucleosides Nucleotides Nucleic Acids. 2001; 20(4-7): 1025-1028.
5.    Kalpana N, Shanmukha Kumar V and Ramachandran D. Development and validation for the simultaneous estimation of Lamivudine, Tenofovir disproxil and Dolutegravir in drug product by RP-HPLC. J Pharm Sci & Res. 2017; 9(9): 1505-1510.
6.    Mallikarjuna Rao N and Gowri Sankar D. Development and validation of stability-indicating HPLC method for simultaneous determination of Lamivudine, Tenofovir, and Dolutegravir in bulk and their tablet dosage form. Future J Pharm Sci. 2015; 1(2): 73-77.
7.    Varaprasad J, Nagendra Kumar P, Pamidi S, Ramaprasad L and Nagaraju D. A stability-indicating HPLC method for the determination of potential impurities in a few fixed dose combination of Dolutegravir, Lamivudine and Tenofovir disoproxil fumarate tablets used in the first line treatment of HIV-1 infection. Int Res J Pharm. 2018; 9(5): 65-74.
8.    Saravanan R, Somanathan T, Gavaskar D and Tamilvanan M. Analytical method development and validation of stability indicating assay method of analysis for Dolutegravir/ Lamivudine/ Tenofovir Disoproxil fumarate tablets using high performance liquid chromatography. Research Journal of Pharmacy and Technology. 2021; 14(5): 2434-2439.
9.    ICH Validation of analytical procedures: Text and methodology Q2 (R1), International Conference on Harmonization (2005).
10.    ICH Stability Testing of New Drug Substances and Products Q1A (R2), International Conference on Harmonization (2003).

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available